One of the most important changes in Ayurveda is not happening in a treatment room. It is happening in how manufacturers think about documentation, claims and accountability.
Rule 158B is part of the regulatory framework governing Ayurvedic, Siddha and Unani medicines. The details can vary by product and regulatory pathway, but the direction for serious manufacturers is clear: heritage alone is not enough. We must be able to explain what a product is, how it is documented and what supports the way it is presented.
For B2B partners, I believe this should change the supplier conversation.
Do not ask only about price, MOQ or lead time. Ask what documentation applies to the product. Ask how quality specifications are maintained. Ask what supports the shelf life. Ask whether the claims on the label and in marketing material are consistent with the product’s regulatory basis.
For export business, ask one more question: has the communication been considered for the destination market?
At Kairali Ayurvedic Products, the standard we should continue to pursue is straightforward: regulatory discipline should sit alongside manufacturing quality, traceability and responsible communication.
Ayurveda has extraordinary heritage. The companies carrying it forward also need systems capable of earning modern B2B trust.
That is not a contradiction. It is how heritage becomes durable.
Leave a Reply